Regulatory Briefs: MAUDE Replacement; Electronic Source Data Guidance; Social Media Monitoring
This article was originally published in The Gray Sheet
Executive Summary
The device center plans to replace the MAUDE adverse events database system by the end of the year. Agency issues final guidance on electronic source data in clinical investigations. FDA purchases social media monitoring software to gauge the effectiveness of its online communications. More regulatory news.
You may also be interested in...
Regulatory Briefs: Microbiology Panel Meeting; Advisory Committee Nomination Portal
FDA’s Microbiology Devices Panel advisory committee will vote on Roche’s cobas HPV Test as a first-line screening test. The agency launched an advisory committee nomination portal and sought nominations for certain device advisory panels. More regulatory news.
Regulatory News In Brief
News on FDA workforce troubles, feedback on CDRH’s eCopy policy and more.
FDA Post-Market Plan Gains Support, But Many Details Still Lacking
A diverse set of stakeholders backed FDA’s new proposed national post-market surveillance plan during a series of public meetings last week, but participants warned “the devil is in the details.”